Bridgeway Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $1.81 Million - $2.54 Million	-135,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $1.35 Million - $2.35 Million	-79,300 Reduced 37.0%	135,000 $2.37 Million
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $147,086 - $696,023	-25,100 Reduced 10.48%	214,300 $5.4 Million
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $92,750 - $266,350	-35,000 Reduced 12.76%	239,400 $1.55 Million
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $285,376 - $474,712	274,400 New	274,400 $445,000

Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $65,625 - $190,750	-87,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $186,375 - $617,750	87,500 New	87,500 $192,000

102

53.5M

51K

31.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $73.3M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.